Wang Y - Search Results

1

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.

Shi Y, Kong Z, Liu P, Hou G, Wu J, Ma W, Cheng X, Wang Y. Shi Y, et al. Among authors: wang y. Cells. 2021 May 10;10(5):1142. doi: 10.3390/cells10051142. Cells. 2021. PMID: 34068501 Free PMC article. Review.

2

Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma.

Kong Z, Jiang C, Liu D, Chen W, Ma W, Cheng X, Wang Y. Kong Z, et al. Among authors: wang y. Clin Nucl Med. 2021 Feb 1;46(2):103-110. doi: 10.1097/RLU.0000000000003406. Clin Nucl Med. 2021. PMID: 33208625

3

Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.

Kong Z, Zhang Y, Liu D, Liu P, Shi Y, Wang Y, Zhao D, Cheng X, Wang Y, Ma W. Kong Z, et al. Among authors: wang y. Ann Nucl Med. 2021 Apr;35(4):493-503. doi: 10.1007/s12149-021-01589-5. Epub 2021 Feb 2. Ann Nucl Med. 2021. PMID: 33532992

4

Anti-PD-1 plus anti-VEGF therapy in multiple intracranial metastases of a hypermutated, IDH wild-type glioblastoma.

Guo X, Wang S, Wang Y, Ma W. Guo X, et al. Among authors: wang y, wang s. Neuro Oncol. 2021 Apr 12;23(4):699-701. doi: 10.1093/neuonc/noab005. Neuro Oncol. 2021. PMID: 33556173 Free PMC article. No abstract available.

5

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation.

Lei C, Chen W, Wang Y, Zhao B, Liu P, Kong Z, Liu D, Dai C, Wang Y, Wang Y, Ma W. Lei C, et al. Among authors: wang y. J Cancer. 2021 May 5;12(13):3796-3808. doi: 10.7150/jca.53827. eCollection 2021. J Cancer. 2021. PMID: 34093788 Free PMC article.

6

Current evidence and challenges of systematic therapies for adult recurrent glioblastoma: Results from clinical trials.

Chen W, Liu D, Liu P, Kong Z, Wang Y, Wang Y, Ma W. Chen W, et al. Among authors: wang y. Chin J Cancer Res. 2021 Jun 30;33(3):417-432. doi: 10.21147/j.issn.1000-9604.2021.03.12. Chin J Cancer Res. 2021. PMID: 34321837 Free PMC article.

7

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress.

Wang Y, Chen W, Shi Y, Yan C, Kong Z, Wang Y, Wang Y, Ma W. Wang Y, et al. Front Oncol. 2021 Sep 9;11:719623. doi: 10.3389/fonc.2021.719623. eCollection 2021. Front Oncol. 2021. PMID: 34568049 Free PMC article. Review.

8

Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation.

Liu D, Yang T, Ma W, Wang Y. Liu D, et al. Among authors: wang y. J Cancer. 2022 Jan 1;13(1):354-363. doi: 10.7150/jca.63595. eCollection 2022. J Cancer. 2022. PMID: 34976195 Free PMC article. Review.

9

Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.

Yang T, Liu D, Fang S, Ma W, Wang Y. Yang T, et al. Among authors: wang y. J Clin Med. 2022 Sep 4;11(17):5221. doi: 10.3390/jcm11175221. J Clin Med. 2022. PMID: 36079151 Free PMC article. Review.

10

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis.

Chen W, Wang Y, Zhao B, Liu P, Liu L, Wang Y, Ma W. Chen W, et al. Among authors: wang y. Front Oncol. 2021 Mar 29;11:641878. doi: 10.3389/fonc.2021.641878. eCollection 2021. Front Oncol. 2021. PMID: 33854975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,225 results

Search Page

Filters